Kaye Scholer Represented Med Opportunity Partners LLC in Acquisition of Reliable Biopharmaceutical Corporation
Kaye Scholer LLP represented Med Opportunity Partners LLC ("MEDOP"), an operating oriented private equity firm, in its acquisition of Reliable Biopharmaceutical Corporation ("RBC"), a developer and manufacturer of active pharmaceutical ingredients and high purity pharmaceutical processing chemicals. RBC's products are the active ingredients for leading generic injectable drugs that treat cancer, heart disease, hypertension, anxiety and other serious illnesses. MEDOP, founded by seasoned healthcare operators and investors, invests in leading niche healthcare companies at their growth stage and in firms that represent healthcare innovation, growth and the opportunity for consolidation.
The Kaye Scholer team included Corporate & Finance partners Bill Wallace, Ed Gabbay and Nancy Fuchs, and associate Jeffrey Misher.